Health
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high rates of adverse side effects, which were mostly mild and gastrointestinal, among patients. A significant […]
Read More
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Test tubes are seen in front of a displayed Abbvie logo in this illustration taken, May 21, 2021. Dado Ruvic | Reuters Biotech stocks rose Thursday as AbbVie announced plans to buy cancer drug developer ImmunoGen for $10.1 billion. Shares of ImmunoGen jumped more than 80% on Thursday, putting it on track for its highest […]
Read More
Jim Cramer blasts the prospect of a Humana-Cigna deal — it could never be approved by regulators
Jim Cramer urged Humana (HUM) not to pursue a merger with rival health insurer Cigna (CI), questioning the merits of a potential business combination and the likelihood of it passing U.S. antitrust review. Cigna and Humana could reach an agreement on a stock-and-cash transaction by the end of the year, The Wall Street Journal reported […]
Read More
Nashville’s startup scene is booming. Here’s why investors and founders are moving to ‘Music City’
NASHVILLE, TENNESSEE – SEPTEMBER 1, 2019: Tourists visit the bars and country music venues in the Lower Broadway entertainment district in Nashville, Tennessee. (Photo by Robert Alexander/Getty Images) Robert Alexander | Archive Photos | Getty Images On a flight from Fort Lauderdale, Florida, to Nashville, Tennessee, earlier this month, 36-year-old Robin Shah settled into his […]
Read More
Covid vaccine rates in the U.S. are slumping — and it will be a challenge to boost them
A sign advertises Covid vaccine shots at a Walgreens Pharmacy in Somerville, Massachusetts, on Aug. 14, 2023. Brian Snyder | Reuters Three years into the Covid-19 pandemic, few Americans are rolling up their sleeves to get a Covid vaccine. Only 15.7% of U.S. adults had received the newest Covid shots from Pfizer, Moderna and Novavax […]
Read More
Citi is so bullish on this biotech stock it gives it 800% potential upside
Citi is so bullish on one biotech firm that it has given its shares a target price that represents around 800% upside. That company is U.S.-listed Biomea Fusion , which develops covalent therapies to treat cancers and metabolic diseases. These therapies offer “a number of potential advantages over conventional non-covalent drugs including greater target selectivity, […]
Read More
Jim Cramer knocks down a new analyst sell rating on a medtech stock as shortsighted
Every weekday the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET. Here’s a recap of Monday’s key moments. 1. Wall Street was mixed Monday after the Dow , the S & P 500 and the Nasdaq finished higher for the fourth straight week. With the last trading day […]
Read More
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
A pharmacist displays a box of Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and made by Lilly at Rock Canyon Pharmacy in Provo, Utah, May 29, 2023. George Frey | Reuters The blockbuster diabetes drug Mounjaro is more effective for weight loss than another highly popular treatment, Ozempic, in overweight or […]
Read More
Here’s how the American Red Cross makes money from donated blood
The American Red Cross has long been recognized as the universal symbol of humanitarian services —and it’s an expensive operation. In 2022, the American Red Cross generated more than $3.2 billion in operating revenue and spent just over $3 billion in expenses the same year, according to its financial statements. Contributions only make up about […]
Read More
Can you hack your brain? These companies are driving innovation in the field of brain stimulation
Deep brain stimulation therapies have been around for decades, but a wave of at-home wearable devices has emerged, forging a pathway toward a new era of electrical brain stimulation that could enhance consumers’ everyday lives — not just treat severe disorders. “Until now, the use of brain stimulation techniques has been relatively restricted to treat […]
Read More